In cancer studies, CXCR6 (C-X-C Motif Chemokine Receptor 6) plays an important role in regulating effector and regulatory T cell recruitment into tumor tissues, thus enabling targeted therapy that promotes local anti-tumor immunity (65–67). This evidence concerns the gene CXCR6 and cancer.